SCHEMBL17261449

SCHEMBL17261449

CCC(=Cc1ccc(OC)cc1)[N+](=O)[O-]

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FBP1 P09467 1/20 0.51
▸ ALDH1A1 P00352 3/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ MAPT P10636 2/20 0.47
▸ HPGD P15428 2/20 0.47
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ NFKB1 P19838 1/20 0.45
▸ APEX1 P27695 1/20 0.45
▸ BLM P54132 1/20 0.45
▸ PMP22 Q01453 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ EGFR P00533 1/20 0.45
▸ ERBB2 P04626 1/20 0.45
▸ CYP2A6 P11509 1/20 0.44
▸ GSK3B P49841 1/20 0.44
▸ MAOA P21397 1/20 0.43
▸ MAOB P27338 1/20 0.43
▸ NFE2L2 Q16236 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17261448 1.00 FBP1 (0.51) FBP1ALDH1A1KDM4EMAPTHPGD
SCHEMBL10401115 0.89 FBP1 (0.50) FBP1ALDH1A1KDM4EMAPTHPGD
SCHEMBL14463648 0.87 FBP1 (0.49) FBP1ALDH1A1KDM4EMAPTHPGD
SCHEMBL8867117 0.87 FBP1 (0.49) FBP1ALDH1A1KDM4EMAPTHPGD
SCHEMBL13092439 0.81 ESR1 (0.50) FBP1ALDH1A1KDM4EMAPTHPGD
SCHEMBL1750291 0.81 FBP1 (0.47) FBP1ALDH1A1MAPTCYP1A2CYP3A4
SCHEMBL1032674 0.81 FBP1 (0.47) FBP1ALDH1A1MAPTCYP1A2CYP3A4
SCHEMBL1971749 0.80 VCP (0.55) ALDH1A1KDM4EMAPTHPGDCYP1A2
SCHEMBL10661512 0.80 ALDH1A1 (0.51) ALDH1A1KDM4EMAPTHPGDNPSR1
SCHEMBL1971750 0.80 VCP (0.55) ALDH1A1KDM4EMAPTHPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3143020-A1 NOVEL DIHYDROQUINOLIZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2017-03-22 — — EP disclosed
WO-2015173164-A1 NOVEL DIHYDROQUINOLIZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2015-11-19 — — WO disclosed
Send feedback